FindTrial
Sign In

Molecular determinants determining Ceftaroline resistance in isolates of Methicillin-Resistant Staphylococcus Aureus identified within routine clinical samples

Molecular determinants for Ceftaroline resistance in Clinical Isolates of Methicillin-Resistant Staphylococcus Aureus: A Cross sectional Pilot Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/07/071620
Enrollment
20
Registered
2024-07-31
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B956- Staphylococcus aureus as the causeof diseases classified elsewhere

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

All India Institute of Medical Sciences Rishikesh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinical samples found to be Methicillin-Resistant Staphylococcus aureus positive obtained from patients of age group more than one years of age, of either gender, admitted to various clinical departments

Exclusion criteria

Exclusion criteria: Patients/relatives inability or refusal for consent

Design outcomes

Primary

MeasureTime frame
Molecular determinants contributing to Ceftaroline resistance in Clinical Isolates of Methicillin-Resistant Staphylococcus aureus (10 ceftaroline sensitive, 10 ceftaroline resistant) using next generation sequencingTimepoint: At baseline, on identifying Methicillin-Resistant Staphylococcus aureus isolates within routine clinical samples reaching the lab for microbiological & sensitivity analysis—

Secondary

MeasureTime frame
Antimicrobial susceptibility pattern of identified Methicillin-Resistant Staphylococcus aureus isolates with respect to Ceftaroline sensitivityTimepoint: At baseline, on identifying Methicillin-Resistant Staphylococcus aureus isolates within routine clinical samples reaching the lab for microbiological & sensitivity analysis;Baseline patient parameters including demographics, patient location, baseline diagnosis, co-morbidities, any risk factors, cannulation, type of sampleTimepoint: At baseline, on identifying Methicillin-Resistant Staphylococcus aureus isolates within routine clinical samples reaching the lab for microbiological & sensitivity analysis—

Countries

India

Contacts

Public ContactDr Gaurav Jain

All India Institute of Medical Sciences Rishikesh

gauravhld@gmail.com8808631209

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026